{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:01:34Z","timestamp":1784937694747,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jacadv.2026.102688","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:40:03Z","timestamp":1773952803000},"page":"102688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial Infarction"],"prefix":"10.1016","volume":"5","author":[{"given":"Jonathan D.","family":"Knott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"De Michieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5230-7037","authenticated-orcid":false,"given":"Olatunde","family":"Ola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1840-0999","authenticated-orcid":false,"given":"Ashok","family":"Akula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Slusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yader","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jacadv.2026.102688_bib1","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102688_bib2","first-page":"546","article-title":"Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction","volume":"11","author":"Knott","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102688_bib3","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","article-title":"Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury","volume":"137","author":"Chapman","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacadv.2026.102688_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamacardio.2022.0043","article-title":"Characteristics and outcomes of type 2 myocardial infarction","volume":"7","author":"Coscia","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.102688_bib5","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1038\/s41598-023-34312-7","article-title":"Management and outcome trends in type 2 myocardial infarction: an investigation from the SWEDEHEART registry","volume":"13","author":"Eggers","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jacadv.2026.102688_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.amjmed.2015.11.035","article-title":"Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction","volume":"129","author":"Baron","year":"2016","journal-title":"Am J Med"},{"issue":"25","key":"10.1016\/j.jacadv.2026.102688_bib7","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.jacc.2021.04.050","article-title":"Clinical impact of high-sensitivity cardiac troponin T implementation in the community","volume":"77","author":"Ola","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.102688_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"12","key":"10.1016\/j.jacadv.2026.102688_bib9","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.amjmed.2017.07.033","article-title":"Using high-sensitivity cardiac troponin T for acute cardiac care","volume":"130","author":"Sandoval","year":"2017","journal-title":"Am J Med"},{"issue":"23","key":"10.1016\/j.jacadv.2026.102688_bib10","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.119.045480","article-title":"Implementing high-sensitivity cardiac troponin T in a US regional healthcare system","volume":"141","author":"Sandoval","year":"2020","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.jacadv.2026.102688_bib11","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2019.02.018","article-title":"Type 2 myocardial infarction","volume":"73","author":"Sandoval","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacadv.2026.102688_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.jacadv.2026.102688_bib13","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.3390\/jcm12196412","article-title":"Coronary artery disease: a key issue in type 2 myocardial infarction: systematic review and recent findings","volume":"12","author":"Yao","year":"2023","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102688_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jamacardio.2019.0716","article-title":"Misclassification of myocardial injury as myocardial infarction: implications for assessing outcomes in value-based programs","volume":"4","author":"McCarthy","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"17","key":"10.1016\/j.jacadv.2026.102688_bib15","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2023.08.020","article-title":"Coronary computed tomographic angiography with fractional flow reserve in patients with type 2 myocardial infarction","volume":"82","author":"McCarthy","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacadv.2026.102688_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055755","article-title":"Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis","volume":"12","author":"White","year":"2022","journal-title":"BMJ Open"},{"issue":"16","key":"10.1016\/j.jacadv.2026.102688_bib17","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.121.058542","article-title":"Coronary artery and cardiac disease in patients with type 2 myocardial infarction: a prospective cohort study","volume":"145","author":"Bularga","year":"2022","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.jacadv.2026.102688_bib18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jacc.2017.07.774","article-title":"Effect of definition on incidence and prognosis of type 2 myocardial infarction","volume":"70","author":"Nestelberger","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacadv.2026.102688_bib19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1213\/ANE.0000000000002580","article-title":"Unexpected cardiac computed tomography findings in patients with postoperative myocardial injury","volume":"126","author":"Grobben","year":"2018","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.jacadv.2026.102688_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.amjmed.2023.03.005","article-title":"Diagnosis and prognosis of type 2 myocardial infarction using objective evidence of acute myocardial ischemia: a validation study","volume":"136","author":"Knott","year":"2023","journal-title":"Am J Med"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26001067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26001067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:06:00Z","timestamp":1784934360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26001067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2772963X26001067"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102688","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Prognostic Implications of Atherosclerotic Coronary Artery Disease in Type 2 Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.102688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102688"}}